Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.33% | 168.13 | 0.7% | $1128.30m | |
| PFE | Pfizer Inc. | -0.50% | 49.61 | 0.9% | $923.63m | |
| ABBV | AbbVie, Inc. | -0.43% | 141.94 | 1.9% | $816.24m | |
| LLY | Eli Lilly & Co. | 2.76% | 318.86 | 1.1% | $806.77m | |
| MRK | Merck & Co., Inc. | 0.98% | 91.48 | 0.7% | $800.70m | |
| BMY | Bristol-Myers Squibb Co. | 1.05% | 74.91 | 1.0% | $652.74m | |
| SIGA | SIGA Technologies, Inc. | 2.24% | 24.86 | 0.0% | $474.56m | |
| AZN | AstraZeneca Plc | 0.05% | 66.77 | 1.0% | $369.83m | |
| GBT | Global Blood Therapeutics, Inc. | 0.12% | 67.08 | 5.6% | $333.13m | |
| GSK | GSK Plc | -1.31% | 34.80 | 0.3% | $280.53m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -0.93% | 226.03 | 8.2% | $273.95m | |
| VERU | Veru, Inc. | 8.58% | 24.16 | 0.0% | $243.44m | |
| HZNP | Horizon Therapeutics Plc | -2.36% | 62.57 | 5.4% | $215.36m | |
| KRTX | Karuna Therapeutics, Inc. | 1.22% | 266.90 | 0.0% | $207.52m | |
| CCXI | ChemoCentryx, Inc. | 0.14% | 50.93 | 2.9% | $202.60m |
Company Profile
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and the Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.